OVASUITE
Live / Applied — First extension granted (statement of use) (as of 12 Mar 2024)
What this means for you
Not registered yet, but its 08 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97584015
- Mark type
- Stylized text
- Filed
- 08 Sept 2022
- Published for opposition
- 01 Aug 2023
- Attorney of record
- Melissa Hunter-Ensor
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing medical information, consultancy and advisory services in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; providing medical information to doctors and patients in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of gynecological oncology and women's health; medical testing for diagnostic or treatment purposes in the field of oncology; medical testing for diagnostic or treatment purposes in the field of ovarian cancer; medical testing for diagnostic or treatment purposes in the field of breast cancer; medical testing for diagnostic or treatment purposes in the field of gynecology; medical testing for diagnostic or treatment purposes in the field of endometriosis; medical testing for diagnostic or treatment purposes in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; medical diagnosis of endometriosis; medical diagnosis of cancer; medical diagnosis of ovarian cancer; medical diagnosis of breast cancer; medical information services, namely, reporting of consumer authorized clinical testing results for clinical review; medical analysis services for the diagnosis of cancer; DNA screening for medical purposes; genetic testing for medical purposes; providing medical information; medical consulting in the field of biological infection disease control
Owner
- Aspira Women's Health Inc., Austin, TX, US
- Aspira Women's Health Inc., Austin, TX, US
Prosecution history
- 13 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2024 — SOU EXTENSION 1 GRANTED
- 12 Mar 2024 — SOU EXTENSION 1 FILED
- 12 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
- 26 Sept 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Aug 2023 — PUBLISHED FOR OPPOSITION
- 12 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jun 2023 — EXAMINER'S AMENDMENT ENTERED
- 24 Jun 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 24 Jun 2023 — EXAMINERS AMENDMENT E-MAILED
- 24 Jun 2023 — EXAMINERS AMENDMENT -WRITTEN
- 22 Jun 2023 — ASSIGNED TO EXAMINER